Subacute Thrombosis Associated With Clopidogrel Resistance: A Case Report
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: WANG, Chia-Ling (Show Chwan Memorial Hospital, Pharmacy, Changhua, China Taiwan)
- Co-author(s): Lai, S.H. (Show Chwan Memorial Hospital, Changhua, China Taiwan)
Chen, C.C. (Show Chwan Memorial Hospital, Changhua, China Taiwan)
Clopidogrel was approved for prevention of thrombotic events. Clopidogrel resistance is a widely used term that has been used to reflect failure of clopidogrel treatment that may increase incidence of coronary, cerebrovascular, and coronary stent thrombosis.
We have experienced a case of recurrent stent thrombosis with The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.